Pancreatic adenocarcinomas were PLK1 positive in 47.7% of cases (out of 86 patient samples) in one study15 and in 80% of cases (out of 140 patient samples) in another48. This evidence concerns the gene PLK1 and pancreatic adenocarcinoma.